We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group Hits 52- Week High on Product Launch, Volumes
Read MoreHide Full Article
On Sep 16, 2016, shares of CME Group Inc. (CME - Free Report) scaled a new 52-week high of $109.80. The upside was driven by product launch and sturdy August volumes. About 1.7 million shares exchanged hands in the last trading session and the stock finally closed at $109.65, up 0.34%. Year to date, the stock has returned 21.03%, which is substantially above 4.74% returned by Nasdaq.
Last week, CME Group unveiled the first-ever, exchange-traded precious metals spread and ratio futures contracts. The market participants will now be able to better manage precious metals price relationships using these contracts. The three newly launched contracts include Gold/Silver Ratio futures, Gold/Platinum Spread futures and Platinum/Palladium Spread futures. CME Group has been driving its growth by strategically offering different types of futures contracts. This, in turn, makes its portfolio a compelling one.
Also, CME Group’s average daily volume for August was 13.8 million contracts per day. Average daily volume for the first eight months improved by 9% to 5.5 million contracts per day. Total open interest of 105 million contracts at the end of August increased 15% over year-end 2015. The company has been able to continually drive growth in average daily volumes owing to its solid operating leverage.
Riding on the core strength, the Zacks Consensus Estimate has also moved up 2.5% for both 2016 and 2017, over the last 60 days.
Continuous focus on expanding and cross sell through strategic alliances, acquisitions, new product initiatives and global presence should drive growth for CME Group. The expected long-term earnings growth rate is pegged at 9.6%.
CME Group presently carries a Zacks Rank #2 (Buy). Other well-ranked stocks from the finance industry include MarketAxess Holdings Inc. (MKTX - Free Report) , Allied World Assurance Company Holdings, AG (AWH - Free Report) and National Interstate Corporation (NATL - Free Report) . While both Allied World Assurance and National Interstate sport a Zacks Rank #1 (Strong Buy), MarketAxess carries Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
CME Group Hits 52- Week High on Product Launch, Volumes
On Sep 16, 2016, shares of CME Group Inc. (CME - Free Report) scaled a new 52-week high of $109.80. The upside was driven by product launch and sturdy August volumes. About 1.7 million shares exchanged hands in the last trading session and the stock finally closed at $109.65, up 0.34%. Year to date, the stock has returned 21.03%, which is substantially above 4.74% returned by Nasdaq.
Last week, CME Group unveiled the first-ever, exchange-traded precious metals spread and ratio futures contracts. The market participants will now be able to better manage precious metals price relationships using these contracts. The three newly launched contracts include Gold/Silver Ratio futures, Gold/Platinum Spread futures and Platinum/Palladium Spread futures. CME Group has been driving its growth by strategically offering different types of futures contracts. This, in turn, makes its portfolio a compelling one.
Also, CME Group’s average daily volume for August was 13.8 million contracts per day. Average daily volume for the first eight months improved by 9% to 5.5 million contracts per day. Total open interest of 105 million contracts at the end of August increased 15% over year-end 2015. The company has been able to continually drive growth in average daily volumes owing to its solid operating leverage.
Riding on the core strength, the Zacks Consensus Estimate has also moved up 2.5% for both 2016 and 2017, over the last 60 days.
Continuous focus on expanding and cross sell through strategic alliances, acquisitions, new product initiatives and global presence should drive growth for CME Group. The expected long-term earnings growth rate is pegged at 9.6%.
CME GROUP INC Price and Consensus
CME GROUP INC Price and Consensus | CME GROUP INC Quote
Zacks Rank and Stocks to Consider
CME Group presently carries a Zacks Rank #2 (Buy). Other well-ranked stocks from the finance industry include MarketAxess Holdings Inc. (MKTX - Free Report) , Allied World Assurance Company Holdings, AG (AWH - Free Report) and National Interstate Corporation (NATL - Free Report) . While both Allied World Assurance and National Interstate sport a Zacks Rank #1 (Strong Buy), MarketAxess carries Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>